Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dilip Dudhat

Dentist, General Practice Colmar, PA Doctor of Dentistry

NPI 1124033774 CMS profile 5266

2406 N Broad St, Colmar, PA 18915

Open in the dashboard

General payments

$49,573

482 records reported · program years 2019–2025

Research payments

$600

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dilip Dudhat of Colmar, PA is reported in the CMS Open Payments database as having received $49,573 across 482 general payments and $600 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,284 82
2024 General $5,243 50
2023 General $10,377 74
2022 General $4,420 67
2021 General $9,782 84
2020 General $7,476 48
2019 General $2,991 77
2019 Research $600 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dilip Dudhat
  • Dentist, General Practice median
  • Middle half of Dentist, General Practice
  • National median

In program year 2025, general payments to Dilip Dudhat were reported at $9,284. Among 41,122 Dentist, General Practice profiles paid that year, the median was $75 and the middle half received between $27 and $200.

Show as a table
Year Dilip Dudhat Dentist, General Practice median Middle half National median
2019 $2,991 $61 $23–$158 $163
2020 $7,476 $73 $24–$142 $114
2021 $9,782 $75 $25–$184 $132
2022 $4,420 $75 $27–$198 $149
2023 $10,377 $77 $28–$200 $160
2024 $5,243 $74 $27–$187 $164
2025 $9,284 $75 $27–$200 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Align Technology, Inc. $8,525 126 payments
  2. A-dec, Inc. $8,314 24 payments
  3. PureLife, LLC $6,696 34 payments
  4. Straumann USA LLC $5,729 79 payments
  5. Neoss, Inc. $3,041 8 payments
  6. Zest Holdings, LLC $2,988 7 payments
  7. Dentsply Sirona Inc $1,617 26 payments
  8. Keystone Dental Inc. $1,338 4 payments
  9. Zimmer Biomet Holdings, Inc. $1,200 16 payments
  10. Envista Holdings Corporation $942 16 payments
  11. Other $9,183 142 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $19,752 351 payments
  2. Gift $18,720 69 payments
  3. Education $5,063 36 payments
  4. Charitable Contribution $1,892 1 payment
  5. Entertainment $1,601 10 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,290 6 payments
  7. Long term medical supply or device loan $550 1 payment
  8. Honoraria $445 4 payments
  9. Consulting Fee $250 3 payments
  10. Debt forgiveness $10 1 payment
Products named General payments · program years 2019–2025
  1. Invisalign $7,275 112 payments
  2. Neoss ProActive Implant Systems $2,984 7 payments
  3. NOBELACTIVE $752 12 payments
  4. Palodent Plus EZ Coat Sectional Matrix System $600 1 payment
  5. iTero Element 5D Plus Lite, Mobile Configuration $550 1 payment
  6. ARESTIN $453 11 payments
  7. Puros $375 5 payments
  8. LUXACROWN A2 $374 1 payment
  9. IMS $346 2 payments
  10. ZIRCONIA ABUTMENT PREPARATION KIT $315 5 payments
  11. Other $7,930 135 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Align Technology, Inc. $600 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

124

Median for Dentist: 47

Drug cost

$301

Median for Dentist: $159

Branded share of claims

0%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 124 $301

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

484 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, General Practice in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record